• Teetering Akorn hit with another FDA warning letter fiercepharma
    June 28, 2019
    For Akorn, when it rains, it monsoons. The sterile and generics maker, whose $4.3 billion buyout by Fresenius was swept away because of manufacturing failures, has received its second warning letter this year, even as it is in the process of renegotiating
  • Adoption of Advanced Health IT Capabilities Inconsistent drugs
    January 17, 2019
    Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with electronic health record (EHR) standardization being the strongest predictor of .....
  • HIT-Related Stress Linked to Burnout Among Physicians drugs
    December 11, 2018
    tress related to use of health information technology (HIT) is common and predictive of burnout among physicians, according to a study published online Dec. 5 in the Journal of the American...
PharmaSources Customer Service